Factors influencing the diagnostic accuracy of the rapid influenza antigen detection test (RIADT): A cross-sectional study

BMJ Open

Volumn 4, Issue 1, 2014, Pages

  Tanei, Mika ^a   Yokokawa, Hirohide ^a   Murai, Kenji ^a   Sakamoto, Rino ^a   Amari, Yu ^a   Boku, Soushin ^a   Inui, Akihiro ^a   Fujibayashi, Kazutoshi ^a   Uehara, Yuki ^a   Isonuma, Hiroshi ^a   Kikuchi, Ken ^a   Naito, Toshio ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGEN DETECTION; ARTHRALGIA; ARTICLE; CHILL; COUGHING; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; FEVER; GENERAL PRACTITIONER; GOLD STANDARD; HEADACHE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYALGIA; PHYSICAL EXAMINATION; PREDICTIVE VALUE; RAPID INFLUENZA ANTIGEN DETECTION TEST; RESPIRATORY VIRUS; SORE THROAT; TEMPERATURE; YOUNG ADULT; BLOOD; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; REPRODUCIBILITY; TIME;

VIRUS ANTIGEN;

ADULT; ANTIGENS, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TIME FACTORS; YOUNG ADULT;

EID: 84892857102     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003885     Document Type: Article

References (32)

1. US Centers for Disease Control and Prevention. Influenza symptoms and the role of laboratory diagnosis. http://www.cdc.gov/flu/professionals/diagnosis/ larolesprocedures.htm (accessed 26 Nov 2012).
2. Mont AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7.
3. Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA 2005;293:987-97. (Pubitemid 40271131)
4. Govaert TME, Dinant GJ, Aretz K, et al. The predictive value of influenza symptomatology in elderly people. Fam Pract 1998;15:16-22. (Pubitemid 28098380)
5. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc 2002;50:1498-503. (Pubitemid 35024641)
6. Bovin G, Hardy I, Teiler G. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000;31:1166.
7. Mitamura K, Sugaya N, Nirasawa M, et al. Impact of influenza A virus infection as a cause of pediatric hospitalization and use of rapid antigen test of influenza A virus. Kansenshogaku Zasshi 1998;72:883-9.
8. Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:1235.
9. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57:1-60.
10. Hayden FG, Osterhaus A, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997;337:874-80. (Pubitemid 27408569)
11. Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367:303-13. (Pubitemid 43151463)
12. Jefferson T, Jones M, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009;339:b5106.
13. Nicholson KG, Aoki FY, Osterhaus A, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000;355:1845-50. (Pubitemid 30311875)
14. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32.
15. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with Flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011;53: 277-9.
16. Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163:1667-72. (Pubitemid 36898954)
17. Sugaya N, Shinjoh M, Mitamura K, et al. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children. J Infect 2011;63:288-94.
18. US Centers for Disease Control and Prevention. Guidance for clinicians on the use of rapid influenza diagnostic tests. http://www.cdc.gov/flu/ professionals/diagnosis/clinician-guidance-ridt.htm (accessed 26 Nov 2012).
19. Chartrand C, Leeflang MMG, Minion J, et al. Accuracy of rapid influenza diagnostic tests. A meta-analysis. Ann Intern Med 2012;156:500-11.
20. Sakai-Tagawa Y, Ozawa M, Tamura D, et al. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol 2010;48:2872-7.
21. Weekly reports of influenza virus isolation/detection, from week 36 of 2010 to week 19 of 2011, Japan. http://idsc.nih.go.jp/iasr/prompt/graph/sinin1e- 1.gif (accessed 30 Oct 2013).
22. The attachment of Rapid Testa FLU II (Sekisui Medical, Tokyo, Japan), http://www.eidia.co.jp/product/diagnose/attach/attach-pdf/ippan/rapid-flu-2.pdf (accessed 30 Oct 2013).
23. Takahashi H, Otsuka Y, Patterson BK. Diagnostic tests for influenza and other respiratory viruses: determining performance specifications based on clinical setting. J Infect Chemother 2010;16:155-61.
24. Boku S, Naito T, Murai K, et al. Near point-of-care administration by the attending physician of the rapid influenza antigen detection immunochromatography test and the fully automated respiratory virus nucleic acid test: contribution to patient management. Diagn Microbiol Infect Dis 2013;76:445-9.
25. Treanor JJ. Influenza virus. In: Mandell GL, Bennett JE, Dolin R. eds. Principles and practice of infectious diseases, 7th edn. Philadelphia: Churchill Livingstone, 2005:2276.
26. Landry ML, Cohen S, Ferguson D. Real-time PCR compared to Binax NOW and cytospin immunofluorescence for detection of influenza in hospitalized patients. J Clin Virol 2008;43:148-51.
27. McGeer AJ. Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do? Clin Infect Dis 2009;48:S14-19.
28. Treanor JJ. Influenza virus. In: Mandell GL, Bennett JE, Dolin R. eds. Principles and practice of infectious diseases, 7th edn. Philadelphia: Churchill Livingstone, 2005:2271-2.
29. Ebell MH, White LL, Casault T. A systematic review of the history and physical examination to diagnose influenza. J Am Board Fam Pract 2004;17:1-5.
30. Tokuda Y, Miyasato H, Stein GH, et al. The degree of chills for risk of bacteremia in acute febrile illness. Am J Med 2005;118:1417.
31. US Centers for Disease Control and Prevention. 2009 H1N1 Situation Update. http://www.cdc.gov/h1n1flu/ (accessed 20 Jun 2013).
32. FDA 510(k) Summary of K103209: Verigene Respiratory Virus Plus Nucleic Acid Test on the Verigene System (RV+). http://www.accessdata.fda.gov/cdrh-docs/ pdf10/K103209.pdf (accessed 30 Oct 2013).